Andrew Lee Lovering

Andrew Lee Lovering

Auto-generated profile, based on publicly available information

Andrew Lee Lovering

School of Biosciences, University of Birmingham, Birmingham, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
MWMark S Wilke
Mark S Wilke
ALAndrew L Lovering
Andrew L Lovering
NSNatalie Cj Strynadka
Natalie Cj Strynadka

7 July 2012 in Annual Review of Biochemistry
Verified
Journal Article
Closed access
ALAndrew L. Lovering
Andrew L. Lovering
SSSusan S. Safadi
Susan S. Safadi
NSNatalie C.J. Strynadka
Natalie C.J. Strynadka
The peptidoglycan biosynthetic pathway is a critical process in the bacterial cell and is exploited as a target for the design of antibiotics. This pathway culminates in the production of the peptidoglycan layer, which is composed of polymerized glycan chains with cross-linked peptide substituents. This layer forms the major structural component of the protective barrier known as the cell wall. Disruption in the assembly of the peptidoglycan layer causes a weakened cell wall and subsequent bacterial lysis. With bacteria responsible for both properly functioning human health (probiotic strains) and potentially serious illness (pathogenic strains), a delicate balance is necessary during clinical intervention. Recent research has furthered our understanding of the precise molecular structures, mechanisms of action, and functional interactions involved in peptidoglycan biosynthesis. This research is helping guide our understanding of how to capitalize on peptidoglycan-based therapeutics and, at a more fundamental level, of the complex machinery that creates this critical barrier for bacterial survival.

9 March 2007 in Science
Verified
Journal Article
Closed access
PDF file
ALAndrew L. Lovering
Andrew L. Lovering
LCLiza H. de Castro
Liza H. de Castro
DLDaniel Lim
Daniel Lim
NSNatalie C. J. Strynadka
Natalie C. J. Strynadka
Peptidoglycan glycosyltransferases (GTs) catalyze the polymerization step of cell-wall biosynthesis, are membrane-bound, and are highly conserved across all bacteria. Long considered the “holy grail” of antibiotic research, they represent an essential and easily accessible drug target for antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus . We have determined the 2.8 angstrom structure of a bifunctional cell-wall cross-linking enzyme, including its transpeptidase and GT domains, both unliganded and complexed with the substrate analog moenomycin. The peptidoglycan GTs adopt a fold distinct from those of other GT classes. The structures give insight into critical features of the catalytic mechanism and key interactions required for enzyme inhibition.

1 April 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PRPaul R. Race
Paul R. Race
ALAndrew L. Lovering
Andrew L. Lovering
RGRichard M. Green
Richard M. Green
AOAbdelmijd Ossor
Abdelmijd Ossor
SWScott A. White
Scott A. White
EHEva I. Hyde
Eva I. Hyde
The antibiotics nitrofurazone and nitrofurantoin are used in the treatment of genitourinary infections and as topical antibacterial agents. Their action is dependent upon activation by bacterial nitroreductase flavoproteins, including the Escherichia coli nitroreductase (NTR). Here we show that the products of reduction of these antibiotics by NTR are the hydroxylamine derivatives. We show that the reduction of nitrosoaromatics is enzyme-catalyzed, with a specificity constant ∼10,000-fold greater than that of the starting nitro compounds. This suggests that the reduction of nitro groups proceeds through two successive, enzyme-mediated reactions and explains why the nitroso intermediates are not observed. The global reaction rate for nitrofurazone determined in this study is over 10-fold higher than that previously reported, suggesting that the enzyme is much more active toward nitroaromatics than previously estimated. Surprisingly, in the crystal structure of the oxidized NTR-nitrofurazone complex, nitrofurazone is oriented with its amide group, rather than the nitro group to be reduced, positioned over the reactive N5 of the FMN cofactor. Free acetate, which acts as a competitive inhibitor with respect to NADH, binds in a similar orientation. We infer that the orientation of bound nitrofurazone depends upon the redox state of the enzyme. We propose that the charge distribution on the FMN rings, which alters upon reduction, is an important determinant of substrate binding and reactivity in flavoproteins with broad substrate specificity.

1 January 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ALAndrew L. Lovering
Andrew L. Lovering
SLSeung Seo Lee
Seung Seo Lee
YKYoung-Wan Kim
Young-Wan Kim
SWStephen G. Withers
Stephen G. Withers
NSNatalie C. J. Strynadka
Natalie C. J. Strynadka
We have determined the first structure of a family 31 α-glycosidase, that of YicI from Escherichia coli, both free and trapped as a 5-fluoroxylopyranosyl-enzyme intermediate via reaction with 5-fluoro-α-d-xylopyranosyl fluoride. Our 2.2-Å resolution structure shows an intimately associated hexamer with structural elements from several monomers converging at each of the six active sites. Our kinetic and mass spectrometry analyses verified several of the features observed in our structural data, including a covalent linkage from the carboxylate side chain of the identified nucleophile Asp416 to C-1 of the sugar ring. Structure-based sequence comparison of YicI with the mammalian α-glucosidases lysosomal α-glucosidase and sucrase-isomaltase predicts a high level of structural similarity and provides a foundation for understanding the various mutations of these enzymes that elicit human disease.

24 June 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
GHGareth W. Hughes
Gareth W. Hughes
SHStephen C. L. Hall
Stephen C. L. Hall
CLClaire S. Laxton
Claire S. Laxton
PSPooja Sridhar
Pooja Sridhar
AMAmirul H. Mahadi
Amirul H. Mahadi
TKTimothy J. Knowles
Timothy J. Knowles